The Progression From Dysmenorrhoea to Chronic Pelvic Pain
CompletedNCT02636972
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a cross-sectional observational study. For participants resident in Adelaide, South Australia. The study consists of 3 visits to the Pain and Anaesthesia Research Clinic (PARC), within the Royal Adelaide Hospital (RAH). A total of 56 participants will be recruited for this study.
Study details
- Official title
- The Progression From Dysmenorrhoea to Chronic Pelvic Pain: Investigation of the Role of Chronic Inflammatory Pain Phenotype in Peripheral Blood as a Potential Biomarker.
- Conditions
- Dysmenorrhoea
- Pelvic Pain
- Chronic Pain
- Interventions
- Drug: OCPs
- Sponsor
- University of Adelaide
- Start date
- 2014-11
- Primary completion
- 2016-01
- Sex
- Female
- Age range
- from 16 Years to 35 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Australia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age between 16 to 35 years old Exclusion Criteria: * Irregular menstrual cycles * Use of any reproductive hormonal preparations (other than the combined oral contraceptive pill), thyroxine, insulin or corticosteroids * Presence of an inflammatory process, or clinically significant infection in the 4 weeks * Clinically significant renal, hepatic, cardiac, auto-immune disease * Current use of immunosuppressant medication such as hydroxychloroquine, methotrexate or azathioprine * Inability to read or comprehend the written information provided * Current use of medications known to affect TLR responsiveness including amitriptyline or minocycline * Current use of any analgesics, including non-steroidal anti-inflammatory medications and opioids for 5 drug half-lives prior to the day of testing * Current or previous pregnancy * Body Mass index less than 18 or more than 30
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02636972